IDEAYA Biosciences (IDYA) Operating Expenses (2018 - 2026)

IDEAYA Biosciences (IDYA) has 9 years of Operating Expenses data on file, last reported at $115.1 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 36.4% year-over-year to $115.1 million; the trailing twelve-month figure through Mar 2026 stood at $408.7 million (up 11.27% YoY), and the FY2025 full-year result was $378.0 million, up 13.19% from the prior year.
• Operating Expenses climbed to $115.1 million in Q1 2026, from $105.4 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $151.1 million in Q4 2024 to a low of $25.6 million in Q1 2022.
• A 5-year average of $64.6 million and a median of $51.0 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses soared 229.71% in 2024 and plunged 30.23% in 2025, its largest moves.
• Tracing IDYA's Operating Expenses over 5 years: stood at $30.5 million in 2022, then surged by 50.46% to $45.8 million in 2023, then soared by 229.71% to $151.1 million in 2024, then sank by 30.23% to $105.4 million in 2025, then gained by 9.16% to $115.1 million in 2026.
• Business Quant data shows IDYA's Operating Expenses at $115.1 million in Q1 2026, $105.4 million in Q4 2025, and $99.4 million in Q3 2025.